Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes
Introduction Pre-eclampsia (PE) is increased ~4-fold by maternal diabetes. Elevated plasma antiangiogenic factors, soluble fms-like tyrosine kinase (sFLT-1) and soluble endoglin (sENG), precede PE onset. We investigated whether diabetes-related stresses, modified lipoproteins and elevated glucose en...
Saved in:
| Main Authors: | Rebecca Helen McLeese, Jiawu Zhao, Dongxu Fu, Jeremy Y Yu, Derek P Brazil, Timothy J Lyons |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-03-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/9/1/e001696.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MBL Interferes with Endovascular Trophoblast Invasion in Pre-Eclampsia
by: Chiara Agostinis, et al.
Published: (2012-01-01) -
Pregnancy in the Setting of Asymptomatic Non-Cirrhotic Chronic Portal Vein Thrombosis Complicated by Pre-Eclampsia
by: Işık Üstüner, et al.
Published: (2013-01-01) -
Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
by: Veronica Giorgione, et al.
Published: (2023-06-01) -
tiRNA-Gln-CTG is Involved in the Regulation of Trophoblast Cell Function in Pre-eclampsia and Serves as a Potent Biomarker
by: Yixiao Wang, et al.
Published: (2025-01-01) -
Role of B7H4 and Fas in regulation of trophoblast cells and development of pre-eclampsia: a cross-sectional study
by: Xiujuan Dong, et al.
Published: (2025-12-01)